loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 18164 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NAPROXEN SODIUM (2)

filter

01 ATNAHS PHARMA US (2)

filter

01 TABLET;ORAL (2)

filter

01 EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 EQ 500MG BASE (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
EQ 250MG BASE **Federa...
ANAPROX
USA
18164
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 500MG BASE
ANAPROX DS
USA
18164
1987-09-30
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 18164

Looking for CTD TGA MCC DOSSIER APPLICATION 18164 2

19

ATNAHS PHARMA UK LIMITED, based in United Kingdom, is a pharmaceutical company.

One of their notable products is NAPROXEN SODIUM, with a corresponding application number 18164 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

ATNAHS PHARMA UK LIMITED's ANAPROX TABLET;ORAL, medication with EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NAPROXEN SODIUM.

18

ATNAHS PHARMA UK LIMITED, based in United Kingdom, is a pharmaceutical company.

One of their notable products is NAPROXEN SODIUM, with a corresponding application number 18164 and regulatory information .

proudly manufactured in the

approval since 1987-09-30

ATNAHS PHARMA UK LIMITED's ANAPROX DS TABLET;ORAL, medication with EQ 500MG BASE of NAPROXEN SODIUM.

Post Enquiry
POST ENQUIRY